← back to search

Kapil D. Sethi

The University of Melbourne · AU
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Botulinum Toxin and Related Neurological Disorders, and Genetic Neurodegenerative Diseases.
h-index
52
citations
13,695
works
305
NIH funding
primary concept
email

Recent publications

The efficacy and safety of bilateral single-session ureteroscopy for bilateral urolithiasis: A systematic review
Asian Journal of Urology 2026cited by 0position: contributordoi
Comparing GreenLight PVP and HoLEP beyond 5 years: A systematic review of long-term functional outcomes and reoperation rates.
2025cited by 2position: contributordoi
Do alpha blockers reduce the risk of urinary retention post-transperineal prostate biopsy? A systematic narrative review.
2024cited by 1position: contributordoi
Predictive value of abbreviated olfactory tests in prodromal Parkinson disease
npj Parkinson s Disease 2023cited by 9position: middledoi
Antiseizure Drugs and Movement Disorders
CNS Drugs 2022cited by 34position: middledoi
Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis.
2022cited by 13position: contributordoi
PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
2022cited by 4position: contributordoi
Ureteric orifice obstruction by catheter balloon Post-TURP: A rare cause of obstructive uropathy.
2022cited by 0position: contributordoi
Corrigendum to "Targeting HIF-1<i>α</i> to Prevent Renal Ischemia-Reperfusion Injury: Does It Work?"
2019cited by 1position: contributordoi
The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study
Journal of Neurology Neurosurgery & Psychiatry 2018cited by 105position: middledoi
Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)
Movement Disorders 2015cited by 149position: middledoi
The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system
Parkinsonism & Related Disorders 2015cited by 112position: middledoi
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
JAMA Neurology 2014cited by 389position: middledoi
Reliability of a new scale for essential tremor
Movement Disorders 2012cited by 240position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2019–2026)Robert A. Hauser · University of South Florida2 papers (2015–2023)Rajesh Pahwa · University of Kansas2 papers (2012–2015) · 2 papers (2018–2022) · 1 papers (2015–2015)Anthony H.V. Schapira · Queen Mary University of London1 papers (2015–2015)Pavan A. Vaswani · Johns Hopkins Medicine1 papers (2023–2023)Stuart Isaacson · Vion Pharmaceuticals (United States)1 papers (2015–2015)Cynthia Comella · Rush University Medical Center1 papers (2012–2012)Pablo Martínez‐Martín · University of Rochester1 papers (2015–2015)Joseph Jankovic · Phillips University1 papers (2012–2012)Marian L. Evatt · Emory University1 papers (2023–2023)Tanya Simuni · Northwestern University1 papers (2023–2023) · 1 papers (2015–2015) · 1 papers (2012–2012)Andrew Siderowf · University of Pennsylvania1 papers (2023–2023) · 1 papers (2015–2015)Dawn Eliashiv · University of California, Los Angeles1 papers (2022–2022)Natividad Stover · University of Alabama at Birmingham1 papers (2012–2012)Ray L. Watts · University of Alabama at Birmingham1 papers (2012–2012)